3 reasons why I own WAM Capital Limited shares

Here is why I think WAM Capital Limited (ASX:WAM) is one of the best managers on the ASX.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It can be quite hard for investors to consistently produce market beating returns every year. Even with the best 'buy and hold' strategy there will be times when the market (and poor quality stocks) outperform the better-quality businesses, whether large or small.

One of the more likely ways to beat the market every single year is to be willing to hold more cash at times. This style isn't suitable for most investors, instead they should stick to the buy and hold method which should outperform the market over the long term assuming you choose the right stocks.

However, there are certain fund managers out there who are active and produce market-beating returns over the short term and long term. One of those great performing managers in my opinion is Wilson Asset Management who run several listed investment companies (LICs).

WAM Capital Limited (ASX: WAM) is one of those LICs and here are three reasons why I'm happy and willing for it to play a part in my portfolio:

Not afraid of cash

The team running WAM Capital aren't afraid to hold a lot of cash when there aren't many opportunities, or when it looks like it's safer to have more cash.

When you have high levels of cash, it protects strongly against market dips and provides ammunition to buy beaten up stocks. It's hard to be a contrarian investor and buy at low prices if you don't have cash to utilise.

In the last three updates of 2016 (December, November and October) it reported cash levels of 33.4%, 35.4% and 39.1%. You may think over the long term having high cash would produce reliable, but lower returns. That brings me to my next point.

Outperformance

WAM Capital has consistently outperformed its benchmark, the S&P/ASX All Ordinaries Accumulation Index, over the short term and long term.

WAM Capital's portfolio has returned 14.5% over the last 12 months whilst its benchmark returned 11.6%, which is still a good return. It's similar when looking at longer timeframes, over 5 and 10 years WAM Capital's portfolio has returned 95% and 121% respectively, whereas the benchmark has returned 58% and 45%.

It's clear that the WAM Capital approach is working, making very satisfying returns whilst also having cash too.

Dividends

WAM Capital has produced great returns in its portfolio, it then pays out a lot of that profit as dividends to shareholders, giving them solid returns and realised cash into the bank account.

It's been raising its dividend every year since the GFC and I imagine it will keep doing so as long as it has the profit reserves. In the half year to December 2016 it has announced it's growing the dividend by 3.45%, which is better than inflation, particularly when you consider how large the dividend yield is.

Risks

Other than the ebb and flow of the overall share market, I think the main risk to WAM Capital is a change to personnel. The current team have shown they have a great strategy and a change in the team could alter how decisions are made, potentially for the worse. For now, the leadership team all seem committed to many more years of investing at WAM.

Time to buy?

You will be hard pressed to buy WAM Capital at a discount to its Net Tangible Assets (NTA) and it generally moves with the market (though hopefully grows quicker than the market). Therefore, I don't think there will be one standout time to buy WAM Capital, but I think it's definitely worth having it play a part in your portfolio.

Motley Fool contributor Tristan Harrison owns shares of WAM Capital Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »